Loading news...
Thousand Oaks Biopharmaceuticals raised $64.2M Series B venture round, led by CICC Capital.
This funding round does not have an about section yet.
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
CICC CapitalLEAD | Private Equity | — |
CITIC SecuritiesLEAD | Investment Bank | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$170.6M
Top Valuation
-
Thousand Oaks Biopharmaceuticals raised $64.2M in a Series B round.
The round was announced on 07/24/20.
The round was led by CICC Capital, CITIC Securities.